InvestorsObserver
×
News Home

Is Onconova Therapeutics Inc (ONTX) a Good Buy in the Healthcare Sector?

Wednesday, June 09, 2021 02:42 PM | InvestorsObserver Analysts

Mentioned in this article

Is Onconova Therapeutics Inc (ONTX) a Good Buy in the Healthcare Sector?

A rating of 78 puts Onconova Therapeutics Inc (ONTX) near the top of the Healthcare sector according to InvestorsObserver.

Onconova Therapeutics Inc's score of 78 means that it ranks higher than 78% of stocks in the sector. In addition, its overall score of 15 ranks it higher than 15% of all stocks.

Overall Score - 15
ONTX has an Overall Score of 15. Find out what this means to you and get the rest of the rankings on ONTX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style.

Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Onconova Therapeutics Inc Stock Today?

Onconova Therapeutics Inc (ONTX) stock is trading at $7.58 as of 2:38 PM on Wednesday, Jun 9, an increase of $0.91, or 13.67% from the previous closing price of $6.67. The stock has traded between $6.56 and $8.00 so far today. Volume today is elevated. So far 2,652,669 shares have traded compared to average volume of 1,955,420 shares.

Click Here to get the full Stock Score Report on Onconova Therapeutics Inc (ONTX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App